MedPath

Identification of Depressive and Anxiety Symptoms Among a Sample of Emergency Department Patients Using Artificial Intelligence (AI) Technology

Not Applicable
Not yet recruiting
Conditions
Artificial Intelligence (AI)
Interventions
Device: Biometrics (or AI Biomaker)
Registration Number
NCT06473558
Lead Sponsor
University Hospitals Cleveland Medical Center
Brief Summary

Behavioral health problems, such as depression and anxiety, are common yet often are not identified by emergency department doctors and nurses. These mental health conditions can be due to medical issues or can worsen medical problems. One way investigators hope to do a better job of learning about mental health is by training Artificial Intelligence (AI) software to detect anxiety and depression by analyzing facial expression and tone of voice.

Participants are invited to participate in a study which may help improve emergency department care. An audio and video recording of the participant's responses to some simple, non-psychological questions will be analyzed by a computer to determine whether investigators can assess mood and anxiety by analyzing speech and visual patterns. The audio and video will not be listened to nor watched by study personnel, only analyzed by a computer. The investigator's hope is that it will help others in the future by aiding in the assessment of psychological state. This study is being conducted at CMC ED only.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Adult patients (age 18 and over) who presents to the UHCMC ED voluntarily with no obvious psychological disturbance by self-report or nurse/provider initial assessment
  • English-speaking
  • Patients with non-emergent concerns of Emergency Severity Index (ESI) level 3, 4, or 5
Exclusion Criteria
  • Prisoners
  • Patients who are deemed to be critically ill (including life or limb threatening illness) or unable to consent
  • Non-English Speaking

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Participants seen at University Hospitals Cleveland Medical Center Emergency DepartmentBiometrics (or AI Biomaker)Eligible patients must present with non-emergent concerns of Emergency Severity Index (ESI) level 3, 4, or 5. Patients will complete assessments and questionnaires and end with being recorded reading a story to capture facial expressions and audio cues.
Primary Outcome Measures
NameTimeMethod
Percentage of participants who score 10-14 on the PHQ-9Baseline

Patient Health Questionnaire (PHQ-9) is a multipurpose instrument for screening, diagnosing, monitoring, and measuring severity of depression. Questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.

Number of participants that AI screened positive for moderate depression symptoms.Baseline
Number of participants that AI screened positive for moderate anxiety symptoms.Baseline
Percentage of participants who score 5-9 on the PHQ-9Baseline

Patient Health Questionnaire (PHQ-9) is a multipurpose instrument for screening, diagnosing, monitoring, and measuring severity of depression. Questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.

Number of participants that AI screened positive for severe depression screeningBaseline
Number of participants that AI screened positive for mild anxiety symptoms.Baseline
Number of participants that AI screened positive for severe anxiety symptoms.Baseline
Percentage of participants who score 15-19 on the PHQ-9Baseline

Patient Health Questionnaire (PHQ-9) is a multipurpose instrument for screening, diagnosing, monitoring, and measuring severity of depression. Questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.

Percentage of participants who score 20-27 on the PHQ-9Baseline

Patient Health Questionnaire (PHQ-9) is a multipurpose instrument for screening, diagnosing, monitoring, and measuring severity of depression. Questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.

Percentage of participants who score 5-9 on the GAD-7Baseline

Generalized Anxiety Disorder (GAD-7) is a easy to preform initial screening tool for generalized anxiety disorder. Questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.

Percentage of participants who score 10-14 on the GAD-7Baseline

Generalized Anxiety Disorder (GAD-7) is a easy to preform initial screening tool for generalized anxiety disorder. Questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.

Percentage of participants who score above 15 on the GAD-7Baseline

Generalized Anxiety Disorder (GAD-7) is a easy to preform initial screening tool for generalized anxiety disorder. Questions are scored on a Likert scale of 0-3 with 0 being not at all and 3 being nearly every day.

Number of participants that AI screened positive for moderately severe depression symptoms.Baseline
Number of participants that AI screened positive for mild depression symptoms.Baseline
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospitals ED

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath